Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-06
1998-02-17
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 530328, 530333, A61K 3813
Patent
active
057191239
ABSTRACT:
Pulmonary administration of Ciclosporin in orthorhombic crystal form (designated "CY-A/X-III"), e.g. for the treatment of obstructive or inflammatory airways disease, e.g. asthma, as well as crystalline Ciclosporin, e.g. CY-A/X-III, in spheroidal particulate form, processes for its preparation and its pharmaceutical use, e.g. for pulmonary administration. Pharmaceutical compositions comprising CY-A/X-III and crystalline Ciclosporin, e.g. CY-A/X-III, in spheroidal particulate form as well as Ciclosporin in solution in aerosol propellants are also provided.
REFERENCES:
Dowling et al., Surgery, vol. 108, No. 2 (1990) PP. 198-205.
List Martin
Morley John
Rummelt Andreas
Honor Robert S.
Kassenoff Melvyn M.
McGovern Thomas O.
Sandoz Ltd.
Schain Howard E.
LandOfFree
Ciclosporin form for pulmonary administration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ciclosporin form for pulmonary administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ciclosporin form for pulmonary administration will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784043